zileuton has been researched along with trans-delta-tocotrienoloic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinh, CP; Helesbeux, JJ; Koeberle, A; Neukirch, K; Richomme, P; Schuster, D; Séraphin, D; Stuppner, H; Temml, V; Viault, G; Ville, A; Werz, O | 1 |
| Alsabil, K; Bernardes, GJL; Bilancia, R; Bréard, D; Brunner, E; Cerqua, I; Dinh, CP; Garscha, U; Gerstmeier, J; Gollowitzer, A; Helesbeux, JJ; Jordan, PM; Koeberle, A; Loeser, K; Lorkowski, S; Marques, MC; Mosig, AS; Neukirch, K; Pace, S; Permann, S; Raasch, M; Richomme, P; Rodrigues, T; Rossi, A; Roviezzo, F; Schuster, D; Séraphin, D; Stuppner, H; Temml, V; Viault, G; Ville, A; Werz, O | 1 |
2 other study(ies) available for zileuton and trans-delta-tocotrienoloic acid
| Article | Year |
|---|---|
Structure-based design, semi-synthesis and anti-inflammatory activity of tocotrienolic amides as 5-lipoxygenase inhibitors.
Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Dose-Response Relationship, Drug; Drug Design; Humans; Lipoxygenase Inhibitors; Molecular Docking Simulation; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship; Vitamin E | 2020 |
Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation.
Topics: Administration, Oral; Arachidonate 5-Lipoxygenase; Dose-Response Relationship, Drug; Drug Discovery; Humans; Inflammation; Lipoxygenase Inhibitors; Molecular Docking Simulation; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship; Vitamin E | 2021 |